The National Academies Press

Currently Skimming:

Index
Pages 211-220

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 211... ... , 145 44-45, 46-47, 72, 86, 101, 104, 105, American College of Gastroenterology, 105 108, 118, 119, 120, 121 American College of Physicians (ACP) , 30, prevalence, 16, 24, 108 32, 33 psychodynamic therapy, 52, 53, 54, American College of Rheumatology, 94 64-65, 66-67, 108, 121 211 Read the entire page →
From page 212... ... , 22, 23, 97 98, 107 Characterizing CMI patient education, 158 causes/underlying factors, 1, 11-13, pharmacologic interventions, 42-43, 203-205 44-45, 95, 96, 99, 105, 114, 116, management vs curing, 26-27 119, 120, 210 prevalence, 2, 23-26 physiological mechanisms, 203-204, 205 risk factors, 26 prevalence in veterans, 16, 24, 25-26, symptoms, 1, 16, 21-22, 23 95-96 terminology, 21-22 Project ECHO, 160 veteran vs civilian populations, 26 psychodynamic therapy, 64-65 working definition, 1, 23 psychotherapy interventions, 54, 60-61, Charge to committee, 2-3, 13-14 68-69, 116, 120 approach to, 3 radiofrequency ablation of branch Chronic fatigue syndrome nerves, 96, 120 clinician–patient communication, 140 REAC-BS treatment, 40, 48-49 and CMI, 1, 3, 4, 15, 18, 23, 29, 32, 97, relaxation techniques, 100, 120 99, 185, 203 Read the entire page →
From page 213... ... study, 76 anxiety, 1, 3, 4, 11, 16, 17, 18, 24, 29, Clinical practice guidelines (CPGs) , 5, 7, 29, 32, 108, 185, 205 30, 32-33, 94, 102, 111, 115, 155, chronic fatigue syndrome, 1, 3, 15, 18, 158-159, 161, 169, 172, 173, 186 23, 29, 32, 97, 99, 185, 203 Clinician-Administered PTSD Scale, 109 chronic pain, 1, 4, 11, 22, 95-96, 107, Cochrane Risk of Bias Tool, 32 114, 118, 159, 185, 186, 205 Cognitive behavioral therapy, 4, 86 depression, 1, 3, 4, 11, 16, 18, 24, 29, for anxiety disorders, 108, 113, 120 32, 106-107, 118, 185 for chronic fatigue syndrome, 54, 68-69, fibromyalgia, 1, 18, 23, 29, 32, 94, 97 99, 120 functional gastrointestinal disorders, 1, for chronic pain, 120 102-106 clinical guidelines, 159 general therapeutic approach, 119-122 clinician training, 135 posttraumatic stress disorder, 4, 11, 26, components, 49 32, 109-111, 185 consultation letter, 70-71 self-harm, 117-118 for depression and suicide risk, 107, sleep disorders, 4, 16, 21, 25-26, 101 113, 119, 121, 122 102, 107, 159, 185 effectiveness, 41, 46-47, 49, 50, 53, somatic symptom disorders, 4, 22, 32, 54-55, 56-63, 95, 115, 120-122, 97, 99, 100-101, 185, 203, 204, 205 184, 185 substance-use disorders, 113-116 exercise plus, 38, 50-51, 60-61, 79, traumatic brain injury, 111-113 84-85, 99, 120, 169, 184 Compensation (see Disability compensation for fibromyalgia, 54, 68-69, 95, 120 for undiagnosed illnesses) Read the entire page →
From page 214... ... , 52, 66-67 Centers (WRIISC) , 4, 6, 7, 9, 160, Escitalopram, 39, 40, 41, 46-47 169, 173, 185, 188, 190, 191 Exercise Depression aerobic, 9, 46-47, 60-61, 68-69, 79, acupuncture for, 107, 121 84-85, 95, 120, 159 biofeedback interventions, 74-75 anxiety, 77, 80-81, 84-85 causes, 203 chronic fatigue syndrome, 99 chronic fatigue syndrome and, 100, 119 chronic pain, 84-85, 99, 116, 120, 158 chronic pain and, 93, 94 cognitive behavioral therapy plus, 38, and CMI, 1, 3, 4, 11, 16, 18, 24, 29, 32, 50-51, 60-61, 79, 84-85, 95, 99, 106-107, 118, 185 120, 159, 169, 184 cognitive behavioral therapy, 107, 113, depression, 77, 80-81, 84-85, 107, 121 119, 121, 122 effectiveness, 79, 84-85 comorbid conditions, 49, 93, 94, 97, fibromyalgia, 95, 120 100, 101, 103-104, 105, 108, 109, Gulf War Veterans' Illnesses, 60-61, 84-85 112, 113, 114, 120, 121 research needs, 9, 191 diagnosis, 16, 106, 116 sleep disorders, 102 electroconvulsive therapy, 107, 121 somatic symptom disorders, 46-47, 53, exercise interventions, 77, 80-81, 84-85, 68-69, 77, 78, 80-81, 84-85 107, 121 strength of evidence, 79, 84 major depressive disorder, 16, 106, 118- substance-use disorders, 116, 122 119, 121 Eye movement desensitization and reprocessing (EMDR) Read the entire page →
From page 215... ... , 166, 167 biofeedback intervention, 66-67 International and Interagency Initiative cause, 94, 203, 205 toward Common Data Elements for clinician–patient communication, 140 Research on Traumatic Brain Injury and CMI, 1, 4, 18, 23, 29, 32, 94, 97 and Psychological Health, 112 cognitive behavioral therapy, 54, 68-69, International Society for Traumatic Stress 95, 120 Studies Guidelines, 111 comorbid conditions, 104 Iraqi War veterans, defined, 1 n.1 diagnostic criteria, 22, 23, 94 Irritable bowel syndrome (IBS) exercise therapy, 95, 120 cause, 203, 204 multimodal therapy, 95, 120 clinician–patient communication, 140, pharmacologic interventions, 33, 38, 40, 210 94-95, 119, 120 and CMI, 1, 3, 18, 22, 23, 29, 97, 103 prevalence, 94 104, 185, 205 symptoms, 3, 22, 94 diagnosis, 23, 103, 203 Functional dyspepsia, 4, 102-103, 104, 105, hypnosis and, 106 121, 185, 204 pharmacologic treatments, 105, 119 Functional gastrointestinal disorders (see prevalence, 103 also Functional dyspepsia; Irritable psychodynamic interventions, 53-54, bowel syndrome) Read the entire page →
From page 216... ... , 170-171, training of clinicians, 7, 8, 47, 69, 79, 172 133-136, 138, 145, 149, 160, 161, postseparation comprehensive health 162, 170, 188-190, 207-210 assessment, 167-169 VHA Office of Patient Centered Care Monoamine oxidase inhibitors, 38 and Cultural Transformation, 160 Motivational interviewing (MI) , 9, 115, Patient–clinician relationship 138-139, 191 communication skills, 7, 8, 136-137, Movement therapies, 63, 76-77, 78 138-139, 140, 207-210 Myalgic encephalomyelitis (see Chronic determinants of good interactions, fatigue syndrome) Read the entire page →
From page 217... ... effectiveness, 42-48 anxiety, 50, 51, 58-59, 60-61, 62-63, fibromyalgia, 33, 40, 94-95, 119, 120 108, 113, 120, 121 functional gastrointestinal disorders, chronic pain, 64-65 105, 119 reviews, 53-54 PTSD, 102, 111, 119, 121 strength of evidence, 55 sleep disorders, 95, 99, 102, 105, 120, for substance-use disorders, 115-116 121 summary of, 54-56 somatic symptom disorders, 39, 40, systematic reviews, 66-71 42-47, 53, 72, 74-75, 101, 119, 120 Pyridostigmine bromide, 13 strength of evidence, 41 substance-use disorders, 115, 122 traumatic brain injury, 113 Q Posttraumatic stress disorder (PTSD) Quick Start program, 166 clinical practice guidelines, 111, 158 and CMI, 4, 11, 26, 32, 109-111, 185 cognitive behavioral therapy, 50, 111, 121 R comorbidities, 96, 101, 102, 104, 109, Radioelectric asymmetric conveyer brain 186 stimulation (REAC-BS) Read the entire page →
From page 218... ... sleep family support, 116 behavior disorder, 101, 205 motivational interviewing, 138 relaxation therapies, 60-61, 100, 121 opioid pain management therapy and, symptoms, 100 114, 116, 122 treatments, 99, 102 patient education, 116 Sleep hygiene, 49, 99-100, 102, 120 pharmacologic treatments, 115, 122 Social media use, 3, 34, 137, 146, 147, 148, psychotherapy, 115-116 149 Suicide and suicidal ideation, 106, 107, Somatic symptom disorders, 100 116, 118-119 biofeedback, 57, 72-73, 74-75, 101, 120 Sulpiride, 39 and CMI, 4, 22, 32, 97, 99, 101, 185, 203, 204, 205 cognitive behavioral therapy, 41, 46-47, T 50, 51, 53, 56-59, 62-63, 68-69, 70-71, 72, 108, 113, 120, 184 Tai Chi, 63, 100, 120 comorbidities, 104, 106, 110 Topiramate, 38, 39, 40, 41, 42-43, 115, 122 diagnosis, 16, 22, 72 Toxic exposures, 12, 13 Read the entire page →
From page 219... ... adherence to, 43, 50-51, 52, 61, 79, War-Related Illness and Injury Study 105, 116, 136, 138, 139, 141 Centers (WRIISC) , 4, 6, 7, 9, 160, general approach for medically 169, 173, 185, 188, 190, 191 unexplained physical symptoms, 12 multimodal approaches, 4, 9, 95, 96-97, 122, 185, 191 Y research recommendations, 8-9, 191 Yoga, 76, 100, 120 Tricyclic medications, 38, 95, 96, 105, 119, 120, 121, 185 Read the entire page →

From page 211...

... , 145 44-45, 46-47, 72, 86, 101, 104, 105, American College of Gastroenterology, 105 108, 118, 119, 120, 121 American College of Physicians (ACP) , 30, prevalence, 16, 24, 108 32, 33 psychodynamic therapy, 52, 53, 54, American College of Rheumatology, 94 64-65, 66-67, 108, 121 211

Read the entire page →

From page 212...

... , 22, 23, 97 98, 107 Characterizing CMI patient education, 158 causes/underlying factors, 1, 11-13, pharmacologic interventions, 42-43, 203-205 44-45, 95, 96, 99, 105, 114, 116, management vs curing, 26-27 119, 120, 210 prevalence, 2, 23-26 physiological mechanisms, 203-204, 205 risk factors, 26 prevalence in veterans, 16, 24, 25-26, symptoms, 1, 16, 21-22, 23 95-96 terminology, 21-22 Project ECHO, 160 veteran vs civilian populations, 26 psychodynamic therapy, 64-65 working definition, 1, 23 psychotherapy interventions, 54, 60-61, Charge to committee, 2-3, 13-14 68-69, 116, 120 approach to, 3 radiofrequency ablation of branch Chronic fatigue syndrome nerves, 96, 120 clinician–patient communication, 140 REAC-BS treatment, 40, 48-49 and CMI, 1, 3, 4, 15, 18, 23, 29, 32, 97, relaxation techniques, 100, 120 99, 185, 203

Read the entire page →

From page 213...

... study, 76 anxiety, 1, 3, 4, 11, 16, 17, 18, 24, 29, Clinical practice guidelines (CPGs) , 5, 7, 29, 32, 108, 185, 205 30, 32-33, 94, 102, 111, 115, 155, chronic fatigue syndrome, 1, 3, 15, 18, 158-159, 161, 169, 172, 173, 186 23, 29, 32, 97, 99, 185, 203 Clinician-Administered PTSD Scale, 109 chronic pain, 1, 4, 11, 22, 95-96, 107, Cochrane Risk of Bias Tool, 32 114, 118, 159, 185, 186, 205 Cognitive behavioral therapy, 4, 86 depression, 1, 3, 4, 11, 16, 18, 24, 29, for anxiety disorders, 108, 113, 120 32, 106-107, 118, 185 for chronic fatigue syndrome, 54, 68-69, fibromyalgia, 1, 18, 23, 29, 32, 94, 97 99, 120 functional gastrointestinal disorders, 1, for chronic pain, 120 102-106 clinical guidelines, 159 general therapeutic approach, 119-122 clinician training, 135 posttraumatic stress disorder, 4, 11, 26, components, 49 32, 109-111, 185 consultation letter, 70-71 self-harm, 117-118 for depression and suicide risk, 107, sleep disorders, 4, 16, 21, 25-26, 101 113, 119, 121, 122 102, 107, 159, 185 effectiveness, 41, 46-47, 49, 50, 53, somatic symptom disorders, 4, 22, 32, 54-55, 56-63, 95, 115, 120-122, 97, 99, 100-101, 185, 203, 204, 205 184, 185 substance-use disorders, 113-116 exercise plus, 38, 50-51, 60-61, 79, traumatic brain injury, 111-113 84-85, 99, 120, 169, 184 Compensation (see Disability compensation for fibromyalgia, 54, 68-69, 95, 120 for undiagnosed illnesses)

Read the entire page →

From page 214...

... , 52, 66-67 Centers (WRIISC) , 4, 6, 7, 9, 160, Escitalopram, 39, 40, 41, 46-47 169, 173, 185, 188, 190, 191 Exercise Depression aerobic, 9, 46-47, 60-61, 68-69, 79, acupuncture for, 107, 121 84-85, 95, 120, 159 biofeedback interventions, 74-75 anxiety, 77, 80-81, 84-85 causes, 203 chronic fatigue syndrome, 99 chronic fatigue syndrome and, 100, 119 chronic pain, 84-85, 99, 116, 120, 158 chronic pain and, 93, 94 cognitive behavioral therapy plus, 38, and CMI, 1, 3, 4, 11, 16, 18, 24, 29, 32, 50-51, 60-61, 79, 84-85, 95, 99, 106-107, 118, 185 120, 159, 169, 184 cognitive behavioral therapy, 107, 113, depression, 77, 80-81, 84-85, 107, 121 119, 121, 122 effectiveness, 79, 84-85 comorbid conditions, 49, 93, 94, 97, fibromyalgia, 95, 120 100, 101, 103-104, 105, 108, 109, Gulf War Veterans' Illnesses, 60-61, 84-85 112, 113, 114, 120, 121 research needs, 9, 191 diagnosis, 16, 106, 116 sleep disorders, 102 electroconvulsive therapy, 107, 121 somatic symptom disorders, 46-47, 53, exercise interventions, 77, 80-81, 84-85, 68-69, 77, 78, 80-81, 84-85 107, 121 strength of evidence, 79, 84 major depressive disorder, 16, 106, 118- substance-use disorders, 116, 122 119, 121 Eye movement desensitization and reprocessing (EMDR)

Read the entire page →

From page 215...

... , 166, 167 biofeedback intervention, 66-67 International and Interagency Initiative cause, 94, 203, 205 toward Common Data Elements for clinician–patient communication, 140 Research on Traumatic Brain Injury and CMI, 1, 4, 18, 23, 29, 32, 94, 97 and Psychological Health, 112 cognitive behavioral therapy, 54, 68-69, International Society for Traumatic Stress 95, 120 Studies Guidelines, 111 comorbid conditions, 104 Iraqi War veterans, defined, 1 n.1 diagnostic criteria, 22, 23, 94 Irritable bowel syndrome (IBS) exercise therapy, 95, 120 cause, 203, 204 multimodal therapy, 95, 120 clinician–patient communication, 140, pharmacologic interventions, 33, 38, 40, 210 94-95, 119, 120 and CMI, 1, 3, 18, 22, 23, 29, 97, 103 prevalence, 94 104, 185, 205 symptoms, 3, 22, 94 diagnosis, 23, 103, 203 Functional dyspepsia, 4, 102-103, 104, 105, hypnosis and, 106 121, 185, 204 pharmacologic treatments, 105, 119 Functional gastrointestinal disorders (see prevalence, 103 also Functional dyspepsia; Irritable psychodynamic interventions, 53-54, bowel syndrome)

Read the entire page →

From page 216...

... , 170-171, training of clinicians, 7, 8, 47, 69, 79, 172 133-136, 138, 145, 149, 160, 161, postseparation comprehensive health 162, 170, 188-190, 207-210 assessment, 167-169 VHA Office of Patient Centered Care Monoamine oxidase inhibitors, 38 and Cultural Transformation, 160 Motivational interviewing (MI) , 9, 115, Patient–clinician relationship 138-139, 191 communication skills, 7, 8, 136-137, Movement therapies, 63, 76-77, 78 138-139, 140, 207-210 Myalgic encephalomyelitis (see Chronic determinants of good interactions, fatigue syndrome)

Read the entire page →

From page 217...

... effectiveness, 42-48 anxiety, 50, 51, 58-59, 60-61, 62-63, fibromyalgia, 33, 40, 94-95, 119, 120 108, 113, 120, 121 functional gastrointestinal disorders, chronic pain, 64-65 105, 119 reviews, 53-54 PTSD, 102, 111, 119, 121 strength of evidence, 55 sleep disorders, 95, 99, 102, 105, 120, for substance-use disorders, 115-116 121 summary of, 54-56 somatic symptom disorders, 39, 40, systematic reviews, 66-71 42-47, 53, 72, 74-75, 101, 119, 120 Pyridostigmine bromide, 13 strength of evidence, 41 substance-use disorders, 115, 122 traumatic brain injury, 113 Q Posttraumatic stress disorder (PTSD) Quick Start program, 166 clinical practice guidelines, 111, 158 and CMI, 4, 11, 26, 32, 109-111, 185 cognitive behavioral therapy, 50, 111, 121 R comorbidities, 96, 101, 102, 104, 109, Radioelectric asymmetric conveyer brain 186 stimulation (REAC-BS)

Read the entire page →

From page 218...

... sleep family support, 116 behavior disorder, 101, 205 motivational interviewing, 138 relaxation therapies, 60-61, 100, 121 opioid pain management therapy and, symptoms, 100 114, 116, 122 treatments, 99, 102 patient education, 116 Sleep hygiene, 49, 99-100, 102, 120 pharmacologic treatments, 115, 122 Social media use, 3, 34, 137, 146, 147, 148, psychotherapy, 115-116 149 Suicide and suicidal ideation, 106, 107, Somatic symptom disorders, 100 116, 118-119 biofeedback, 57, 72-73, 74-75, 101, 120 Sulpiride, 39 and CMI, 4, 22, 32, 97, 99, 101, 185, 203, 204, 205 cognitive behavioral therapy, 41, 46-47, T 50, 51, 53, 56-59, 62-63, 68-69, 70-71, 72, 108, 113, 120, 184 Tai Chi, 63, 100, 120 comorbidities, 104, 106, 110 Topiramate, 38, 39, 40, 41, 42-43, 115, 122 diagnosis, 16, 22, 72 Toxic exposures, 12, 13

Read the entire page →

From page 219...

... adherence to, 43, 50-51, 52, 61, 79, War-Related Illness and Injury Study 105, 116, 136, 138, 139, 141 Centers (WRIISC) , 4, 6, 7, 9, 160, general approach for medically 169, 173, 185, 188, 190, 191 unexplained physical symptoms, 12 multimodal approaches, 4, 9, 95, 96-97, 122, 185, 191 Y research recommendations, 8-9, 191 Yoga, 76, 100, 120 Tricyclic medications, 38, 95, 96, 105, 119, 120, 121, 185

Read the entire page →

← Previous Chapter Skim

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Index Pages 211-220

Index
Pages 211-220